Hikma Pharmaceuticals Plc
(LSE) HIK
Hikma Pharmaceuticals Plc Financials at a Glance
Market Cap
$283.87B
Revenue (TTM)
$6.48B
Net Income (TTM)
$761.79M
EPS (TTM)
$138.16
P/E Ratio
9.44
Dividend
$62.51
Beta (Volatility)
-0.03 (Low)
Dividend
$62.51
Beta (Volatility)
-0.03 (Low)
Price
$1308.00
Volume
1,165,396
Open
$1284.00
Price
$1308.00
Volume
1,165,396
Open
$1284.00
Previous Close
$1308.00
Daily Range
$1271.85 - $1308.00
52-Week Range
$1187.00 - $2164.00
Dividend
$62.51
Beta (Volatility)
-0.03 (Low)
Price
$1308.00
Volume
1,165,396
Open
$1284.00
Previous Close
$1308.00
Daily Range
$1271.85 - $1308.00
52-Week Range
$1187.00 - $2164.00
HIK News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hikma Pharmaceuticals Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
9,400
CEO
Riad Mishlawi
Website
www.hikma.comHeadquarters
London, W1S 2HR, GB
HIK Financials
Key Financial Metrics (TTM)
Gross Margin
41%
Operating Margin
17%
Net Income Margin
12%
Return on Equity
16%
Return on Capital
13%
Return on Assets
7%
Earnings Yield
10.59%
Dividend Yield
0.05%
Payout Ratio
45.16%
Stock Overview
Market Cap
$283.87B
Shares Outstanding
217.03M
Volume
1.17M
Short Interest
0.00%
Avg. Volume
1.35M
Financials (TTM)
Gross Profit
$1.37B
Operating Income
$637.09M
EBITDA
$853.54M
Operating Cash Flow
$366.53M
Capital Expenditure
$201.13M
Free Cash Flow
$165.40M
Cash & ST Invst.
$354.13M
Total Debt
$1.65B
Hikma Pharmaceuticals Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.70B
+17.3%
Gross Profit
$673.22M
-2.7%
Gross Margin
39.62%
N/A
Market Cap
$283.87B
N/A
Market Cap/Employee
$29.88M
N/A
Employees
9,500
N/A
Net Income
$164.79M
+179.3%
EBITDA
$410.96M
+19.1%
Quarterly Fundamentals
Net Cash
$1.30B
-31.4%
Accounts Receivable
$1.08B
+36.8%
Inventory
$1.11B
+24.2%
Long Term Debt
$1.54B
+49.1%
Short Term Debt
$114.04M
-29.2%
Return on Assets
7.10%
N/A
Return on Invested Capital
13.38%
N/A
Free Cash Flow
$101.56M
-66.3%
Operating Cash Flow
$228.94M
-40.7%